These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages. Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031 [TBL] [Abstract][Full Text] [Related]
23. Mediation of the relationship between proteinuria and serum phosphate: Insight from the KNOW-CKD study. Jung JY; Ro H; Chang JH; Kim AJ; Lee HH; Han SH; Yoo TH; Lee KB; Kim YH; Kim SW; Park SK; Chae DW; Oh KH; Ahn C; Chung W PLoS One; 2020; 15(6):e0235077. PubMed ID: 32569271 [TBL] [Abstract][Full Text] [Related]
24. Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate. Pavik I; Jaeger P; Kistler AD; Poster D; Krauer F; Cavelti-Weder C; Rentsch KM; Wüthrich RP; Serra AL Kidney Int; 2011 Jan; 79(2):234-40. PubMed ID: 20944552 [TBL] [Abstract][Full Text] [Related]
26. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M; Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495 [TBL] [Abstract][Full Text] [Related]
27. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD. Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151 [TBL] [Abstract][Full Text] [Related]
28. A decreased soluble Klotho level with normal eGFR, FGF23, serum phosphate, and FEP in an ADPKD patient with enlarged kidneys due to multiple cysts. Kanai T; Shiizaki K; Betsui H; Aoyagi J; Yamagata T CEN Case Rep; 2018 Nov; 7(2):259-263. PubMed ID: 29767399 [TBL] [Abstract][Full Text] [Related]
30. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease. Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182 [TBL] [Abstract][Full Text] [Related]
31. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate. Xie J; Yoon J; An SW; Kuro-o M; Huang CL J Am Soc Nephrol; 2015 May; 26(5):1150-60. PubMed ID: 25475745 [TBL] [Abstract][Full Text] [Related]
32. New insights into the FGF23-Klotho axis. Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378 [TBL] [Abstract][Full Text] [Related]
33. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients. Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931 [TBL] [Abstract][Full Text] [Related]
34. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Quarles LD Exp Cell Res; 2012 May; 318(9):1040-8. PubMed ID: 22421513 [TBL] [Abstract][Full Text] [Related]
35. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats. Muñoz-Castañeda JR; Herencia C; Pendón-Ruiz de Mier MV; Rodriguez-Ortiz ME; Diaz-Tocados JM; Vergara N; Martínez-Moreno JM; Salmerón MD; Richards WG; Felsenfeld A; Kuro-O M; Almadén Y; Rodríguez M FASEB J; 2017 Sep; 31(9):3858-3867. PubMed ID: 28515153 [TBL] [Abstract][Full Text] [Related]
37. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease. Sawires HK; Essam RM; Morgan MF; Mahmoud RA Nephron; 2015; 129(4):293-9. PubMed ID: 25766835 [TBL] [Abstract][Full Text] [Related]
38. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study. Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324 [TBL] [Abstract][Full Text] [Related]
39. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system. Prié D; Friedlander G Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257 [TBL] [Abstract][Full Text] [Related]
40. Regulation of mineral metabolism by lithium. Fakhri H; Pathare G; Fajol A; Zhang B; Bock T; Kandolf R; Schleicher E; Biber J; Föller M; Lang UE; Lang F Pflugers Arch; 2014 Mar; 466(3):467-75. PubMed ID: 24013758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]